Do No Harm v. Pfizer Inc.

126 F.4th 109 (2d Cir. 2025) · United States Court of Appeals for the Second Circuit · January 10, 2025 · No. 23-15

Summary

The Second Circuit vacated and remanded a district court's dismissal of a civil rights lawsuit alleging racial discrimination in Pfizer's Breakthrough Fellowship Program. The appellate court held that the district court incorrectly applied the higher evidentiary burden for establishing Article III standing at the preliminary injunction stage to dismiss the case entirely. Instead, the court instructed the district court to reassess standing using the lower pleading-stage standard applicable at the motion-to-dismiss phase.

Court
United States Court of Appeals for the Second Circuit
Writing for the Court
Dennis Jacobs; Peter W. Hall; Raymond J. Lohier Jr.
Jurisdiction
United States Court of Appeals for the Second Circuit
Decision date
January 10, 2025
Docket number
23-15
Procedural posture
Do No Harm appealed the Southern District of New York's sua sponte dismissal without prejudice for lack of Article III standing after the district court denied Do No Harm's motion for a preliminary injunction. The Second Circuit granted rehearing, vacated its prior published decision affirming the dismissal, vacated the district court's dismissal, and remanded.
Standard of review
The dismissal for lack of standing was reviewed de novo.
Precedential value
Published and precedential
Parties
Do No Harm v. Pfizer Inc.
Disposition
vacated

Topics

standingsubject matter jurisdictionappellate procedureappellate jurisdictioncivil procedure

Practice areas

civil procedureconstitutional lawcivil rightsappellate procedure

Questions Presented

  1. Whether a plaintiff's failure to establish Article III standing under the evidentiary standard applicable to a motion for a preliminary injunction requires dismissal of the action.
  2. Whether standing at the pleading stage may be established through allegations even when the plaintiff failed to produce sufficient evidence to establish standing for preliminary injunctive relief.
  3. Whether the district court's alternative merits-based grounds for dismissing federal claims were premature when the court had not properly resolved Article III jurisdiction.

Holdings

  1. A plaintiff's failure to establish standing to obtain a preliminary injunction does not automatically require dismissal of the entire action when the failure results from insufficient evidence rather than a legally deficient theory of standing.
  2. When a plaintiff fails to establish standing for a preliminary injunction but its alleged standing may be supported under the pleading standard, the district court must assess whether the complaint sufficiently alleges Article III standing before dismissing the action.
  3. The district court's alternative merits-based dismissal of federal claims was premature because the court lacked authority to reach the merits before properly resolving Article III jurisdiction.

Key quotations

The evidentiary burden for establishing Article III standing for the purposes of a motion for a preliminary injunction is at least as onerous as the burden for establishing standing to secure a summary judgment.
By contrast, at the dismissal stage a plaintiff can establish standing on the basis of allegations.
Accordingly, when a plaintiff fails to establish standing to secure a preliminary injunction, the plaintiff may maintain the action if the allegations in the complaint are sufficient to support standing under the standard applicable at the pleadings stage.

Factual background

Pfizer sponsored a Breakthrough Fellowship Program intended to increase minority representation and described eligibility criteria referring to Black/African American, Latino/Hispanic, and Native American applicants. Do No Harm, a nationwide membership organization, alleged that the program excluded white and Asian-American applicants and asserted associational standing based on two pseudonymous members who claimed they were ready and able to apply if the allegedly discriminatory criteria were removed. Pfizer later represented that it changed the program's selection criteria and opened eligibility regardless of whether applicants belonged to the identified racial groups.

Procedural history

Do No Harm sued Pfizer over eligibility criteria for Pfizer's Breakthrough Fellowship Program and sought a temporary restraining order and preliminary injunction. The district court denied preliminary injunctive relief after applying a summary-judgment-level evidentiary burden to standing, then dismissed the case without prejudice, treating the failure to establish standing for preliminary relief as conclusive. The Second Circuit held that the district court applied the wrong standard to dismissal because standing at the pleading stage may be established through allegations, and remanded for the district court to assess standing under that standard and address other jurisdictional issues as appropriate.

Remand instructions

The district court must assess Do No Harm's Article III standing under the pleading-stage standard if Pfizer moves to dismiss on standing grounds, and may address other jurisdictional questions in the order it deems appropriate. Do No Harm's motion to supplement the appellate record is denied as moot.

Court Document

Open PDF
Loading document…